Trastuzumab deruxtecan in HER2-overexpressing metastatic non-small cell lung cancer: Interim results of DESTINY-Lung01 Meeting Abstract


Authors: Nakagawa, K.; Nagasaka, M.; Felip, E.; Pacheco, J.; Baik, C.; Goto, Y.; Saltos, A.; Li, B.; Udagawa, H.; Gadgeel, S.; Murakami, H.; Planchard, D.; Bazhenova, L.; Paz-Ares, L.; Perol, M.; Mazieres, J.; Barlesi, F.; Saxena, K.; Shiga, R.; Acharyya, S.; Cheng, Y.; Shahidi, J.; Jänne, P.; Smit, E.
Abstract Title: Trastuzumab deruxtecan in HER2-overexpressing metastatic non-small cell lung cancer: Interim results of DESTINY-Lung01
Meeting Title: 2020 World Conference on Lung Cancer
Keywords: cancer; trastuzumab deruxtecan; her2-expressing; metastatic non-small cell lung
Journal Title: Journal of Thoracic Oncology
Volume: 16
Issue: 3 Suppl.
Meeting Dates: 2021 Jan 28-31
Meeting Location: Singapore
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2021-03-01
Start Page: S109
End Page: S110
Language: English
ACCESSION: WOS:000631349600085
PROVIDER: wos
DOI: 10.1016/j.jtho.2021.01.285
Notes: Meeting Abstract: OA04.05 -- Due to Covid-19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Bob Tingkan Li
    278 Li
Related MSK Work